AI In Oncology Market Insights 2023, Analysis and Forecast to 2030.
Stats And Research
Syndicated Reports | On-Demand Reports | Subscription Plans | Consulting Services | ESG Solutions - Stats And Research ?
This report describes the global market size of AI In Oncology Market from 2018 to 2021 and its CAGR from 2018 to 2021, and also forecasts its market size to the end of 2030 and its expected to grow with a CAGR of 34.6% from 2023 to 2030.
AI in oncology helps in the correct detection of malignant and precancerous lesions, minimising the need for overtreatment. In light of this, colposcopic image evaluation supported by AI algorithms has demonstrated great accuracy in identifying precancerous lesions in cervical cancer screening.
Get a Free Sample Copy of the Report @:www.statsandresearch.com/request-sample/40200-global-ai-in-oncology-market
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for AI In Oncology Market estimated at US $ million in the year 2022, is projected to reach a revised size of US$ million by 2030, growing at a CAGR of 34.6% during the forecast period 2023-2030. North American market for AI In Oncology Market is estimated to increase from $million in 2022 to reach $ million by 2030, at a CAGR of % during the forecast period of 2023 through 2030.
For geography segment, regional supply, demand, major players, price is presented from 2018 to 2030. This report cover following regions:
North America
Asia-Pacific
Europe
Middle East and Africa
South America
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of AI In Oncology Market as well as some small players. The information for each competitor include:
Company Profile
Main Business Information
SWOT Analysis
Sales Volume, Revenue, Price and Gross Margin
Market Share
By Component Type
Software Solutions
Hardware
Services
Due to the growing use of software solutions for the development of optimised oncological products and the better results linked to their use, the software solutions segment, which had a 44.0% market share in 2022, is expected to grow at the fastest rate during the forecast period. The market's leading competitors are also concentrating on creating cutting-edge solutions to make the products available to the vast majority of people.
By Cancer Type
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
Other held the highest share of 21.7% in 2022, followed by the breast cancer segment, which is expected to rise at a healthy rate throughout the forecasted period. The rising incidence of breast cancer in the population is blamed for the segment's domination. According to the American Society of Clinical Oncology, there were approximately 2,261,419 new cancer cases reported worldwide in 2020. The majority of these instances are found in the United States, where there will likely be 297,790 new cases of breast cancer by 2023. The population's increasing prevalence of cases is driving the demand for technologically sophisticated items, which is fueling the market's overall expansion.
领英推荐
By Treatment Type
Chemotherapy
Radiotherapy
Immunotherapy
Others
With a 36.5% market share in 2022, the chemotherapy category held the majority of the market. The American Cancer Society estimates that 60% of patients with Stage 4 bladder cancer receive chemotherapy, which is a regularly utilised cancer treatment method. By incorporating AI into chemotherapy, medical personnel may better understand each patient's unique digital profile and adjust the patient's dose accordingly. Research efforts to include AI into chemotherapy have increased, which has sped up market expansion. Additionally, the use of AI to deliver customised chemotherapy with lower dosage and fewer side effects promotes the use of chemotherapy.
By Region
North America
APAC
Europe
South America
Middle East & Africa
With a 56.0% market share, North America held the largest portion of the global AI in oncology market in 2022 as a result of the region's advanced digital infrastructure, favourable regulatory and reimbursement frameworks, and growing government initiatives to promote the implementation of AI technology in the healthcare sector. The increasing incidence of various cancers is driving the demand for the creation of cutting-edge therapies and diagnostics, which is further facilitating regional market expansion.
By Company
Azra AI , IBM , Siemens Healthcare FZ LLC , 英特尔 , GE医疗 , NVIDIA Taiwan , Digital Diagnostics , ConcertAI , Median Technologies , PathAI
Please ask for sample pages for full companies list
Buy this Report @:www.statsandresearch.com/placeorder?report=40200-global-ai-in-oncology-market&type=su
Any special requirements about this report, please let us know and we can provide custom report.
About Us
Stats and Research?is a global market research and consulting service provider specialized in offering wide range of business solutions to their clients including market research reports, primary and secondary research, demand forecasting services, focus group analysis and other services. We understand that how data is important in today's competitive environment and thus, we have collaborated with industry's leading research providers who works continuously to meet the ever-growing demand for market research reports throughout the year.
Contact:
Stats and Research
Phone: +1 650-646-3808
Email:?[email protected]